Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Brinker, Baker Hughes fall; Anthem, Abbott Laboratories rise

10/20/2021 | 04:21pm EST

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday:

Canadian National Railway Co., up $6.50 to $130.79.

The railroad operator beat Wall Street's third-quarter profit and revenue forecasts.

Anthem Inc., up $30.30 to $424.05.

The health insurer's third-quarter profit beat analysts' forecasts.

Brinker International Inc., down $4.74 to $44.21.

The owner of the Chili’s Grill & Bar and Maggiano’s Little Italy restaurant chains warned investors higher commodity and labor costs would hurt profits.

Lithia Motors Inc., up $3.30 to $342.01.

The auto dealership chain handily beat Wall Street's third-quarter profit and revenue forecasts.

WD-40 Co., down $20.09 to $209.20.

The maker of lubricants and degreasers' fiscal fourth-quarter profit fell far short of Wall Street forecasts.

Baker Hughes Co., down $1.52 to $25.35.

The oilfield services company reported weak third-quarter financial results as it faces supply chain problems and higher costs.

Abbott Laboratories, up $3.97 to $123.31.

The maker of infant formula and medical devices handily beat analysts’ third-quarter profit forecasts.

Knight-Swift Transportation Holdings Inc., up $3.57 to $54.32.

The trucking company reported encouraging third-quarter financial results on strong shipping demand.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES -0.10% 125.68 Delayed Quote.14.87%
ANTHEM, INC. 2.01% 414.035 Delayed Quote.26.52%
BAKER HUGHES COMPANY 3.08% 24.05 Delayed Quote.11.94%
BRINKER INTERNATIONAL, INC. 4.31% 35.89 Delayed Quote.-38.84%
CANADIAN NATIONAL RAILWAY COMPANY 1.09% 163.92 Delayed Quote.15.66%
All news about ABBOTT LABORATORIES
11/29Thermo Fisher says its COVID-19 tests accurately detects Omicron variant
RE
11/18INSIDER SELL : Abbott Laboratories
MT
11/17Abbott launches similac 360 total care with exclusive blend of five hmo prebiotics and ..
AQ
11/16Abbott Laboratories Launches Similac 360 Total Care Infant Formula
MT
11/16Abbott Launches Similac« 360 Total Care« with Exclusive Blend of Five HMO Prebiotics an..
PR
11/16Abbott Launches Similac? 360 Total Care? with Exclusive Blend of Five Hmo Prebiotics an..
CI
11/16Talis Biomedical Names Brian Blaser Chief Executive
MT
11/15Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow..
PR
11/15Abbott's new leadless pacemaker system meets primary endpoints in pivotal trial
AQ
11/12Abbott Laboratories Says its New Leadless Pacemaker Meets Safety, Efficacy Endpoints
MT
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Financials (USD)
Sales 2021 42 030 M - -
Net income 2021 6 560 M - -
Net Debt 2021 8 142 M - -
P/E ratio 2021 34,0x
Yield 2021 1,35%
Capitalization 222 B 222 B -
EV / Sales 2021 5,49x
EV / Sales 2022 5,66x
Nbr of Employees 109 000
Free-Float 88,5%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 125,77 $
Average target price 135,94 $
Spread / Average Target 8,09%
EPS Revisions
Managers and Directors
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES14.87%222 397
MEDTRONIC PLC-8.91%143 497
BECTON, DICKINSON AND COMPANY-5.23%67 353
HOYA CORPORATION26.28%58 627
DEXCOM, INC.52.17%54 527
SARTORIUS STEDIM BIOTECH79.05%54 174